SI1071702T1 - Fatty acid derivatives of bile acids and bile acid derivatives - Google Patents

Fatty acid derivatives of bile acids and bile acid derivatives

Info

Publication number
SI1071702T1
SI1071702T1 SI9930142T SI9930142T SI1071702T1 SI 1071702 T1 SI1071702 T1 SI 1071702T1 SI 9930142 T SI9930142 T SI 9930142T SI 9930142 T SI9930142 T SI 9930142T SI 1071702 T1 SI1071702 T1 SI 1071702T1
Authority
SI
Slovenia
Prior art keywords
bile
acid derivatives
acid
fatty acid
bile salt
Prior art date
Application number
SI9930142T
Other languages
English (en)
Slovenian (sl)
Inventor
Tuvia Gilat
Original Assignee
Galmed International Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galmed International Ltd. filed Critical Galmed International Ltd.
Publication of SI1071702T1 publication Critical patent/SI1071702T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
SI9930142T 1998-04-08 1999-03-25 Fatty acid derivatives of bile acids and bile acid derivatives SI1071702T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12399898A IL123998A (en) 1998-04-08 1998-04-08 Conjugates of bile salts and pharmaceutical preparations containing them
PCT/IL1999/000173 WO1999052932A1 (en) 1998-04-08 1999-03-25 Fatty acid derivatives of bile acids and bile acid derivatives

Publications (1)

Publication Number Publication Date
SI1071702T1 true SI1071702T1 (en) 2003-04-30

Family

ID=11071405

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930142T SI1071702T1 (en) 1998-04-08 1999-03-25 Fatty acid derivatives of bile acids and bile acid derivatives

Country Status (25)

Country Link
US (3) US6395722B1 (pt)
EP (1) EP1071702B1 (pt)
JP (1) JP5031942B2 (pt)
KR (1) KR100615560B1 (pt)
CN (1) CN100386339C (pt)
AT (1) ATE222923T1 (pt)
AU (1) AU742944B2 (pt)
BR (1) BRPI9909908B8 (pt)
CA (1) CA2325933C (pt)
CZ (1) CZ300824B6 (pt)
DE (1) DE69902647T2 (pt)
DK (1) DK1071702T3 (pt)
EA (1) EA003392B1 (pt)
ES (1) ES2183526T3 (pt)
HU (1) HU229513B1 (pt)
ID (1) ID26042A (pt)
IL (1) IL123998A (pt)
NO (1) NO316875B1 (pt)
NZ (1) NZ507309A (pt)
PL (1) PL199271B1 (pt)
PT (1) PT1071702E (pt)
SI (1) SI1071702T1 (pt)
TR (1) TR200002876T2 (pt)
UA (1) UA70318C2 (pt)
WO (1) WO1999052932A1 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142650A (en) 1998-04-08 2007-06-03 Galmed Int Ltd Use of bile acid conjugates or bile salts and fatty acids or fatty acids in the preparation of pharmaceuticals for lowering cholesterol, for the treatment of fatty liver and for the treatment of hyperglycemia and diabetes
IL123998A (en) * 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US8975246B2 (en) 2001-04-17 2015-03-10 Galmed Research And Development Ltd. Bile acid or bile salt fatty acid conjugates
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
ITMI20021025A1 (it) * 2002-05-14 2003-11-14 Nicox Sa Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale
US20080026077A1 (en) * 2002-11-12 2008-01-31 John Hilfinger Methods and compositions of gene delivery agents for systemic and local therapy
US7906137B2 (en) * 2004-05-21 2011-03-15 Mediplex Corporation, Korea Delivery agents for enhancing mucosal absorption of therapeutic agents
US8304383B2 (en) * 2005-11-22 2012-11-06 Atheronova Operations, Inc. Dissolution of arterial plaque
US20090035348A1 (en) * 2005-11-22 2009-02-05 Z & Z Medical Holdings, Inc. Dissolution of arterial plaque
WO2007084549A2 (en) * 2006-01-20 2007-07-26 Filiberto Zadini Drug-eluting stent with atherosclerotic plaques dissolving pharmacological preparation
US20080038385A1 (en) * 2006-03-13 2008-02-14 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
US20070212470A1 (en) * 2006-03-13 2007-09-13 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
US20090305943A1 (en) * 2006-07-18 2009-12-10 Sven Siegel Cyclodextrin blends with crystal growth inhibitors
CA2685127C (en) 2007-04-23 2019-01-08 Alnylam Pharmaceuticals, Inc. Glycoconjugates of rna interference agents
WO2008144458A1 (en) * 2007-05-15 2008-11-27 Z & Z Medical Holdings, Inc. Dissolution of arterial cholesterol plaques by pharmacologically induced elevation of endogenous bile salts
SI2182954T1 (sl) * 2007-07-25 2019-04-30 Medizinische Universitat Graz Uporaba nor-žolčnih kislin pri zdravljenju arterioskleroze
CN101367859B (zh) * 2007-08-17 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 脂肪酸胆汁酸偶合物及其医药用途
CZ301037B6 (cs) * 2007-09-06 2009-10-21 Vysoká škola chemicko-technologická v Praze Amidové konjugáty steroidních a žlucových kyselin s D-glukosaminem a zpusob jejich prípravy
EP2231194B1 (en) 2007-12-04 2017-02-22 Alnylam Pharmaceuticals Inc. Folate-irna conjugates
CA2708173C (en) 2007-12-04 2016-02-02 Alnylam Pharmaceuticals, Inc. Targeting lipids
US20100021538A1 (en) * 2008-02-29 2010-01-28 Youngro Byun Pharmaceutical compositions containing heparin derivatives
WO2009126933A2 (en) 2008-04-11 2009-10-15 Alnylam Pharmaceuticals, Inc. Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
CA2779413A1 (en) 2008-11-03 2010-06-03 Tufts University Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth
US20120157419A1 (en) * 2009-02-02 2012-06-21 Tuvia Gilat Methods and compositions for treating alzheimer's disease
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
CN102115486B (zh) * 2009-12-30 2015-06-03 上海特化医药科技有限公司 一种3-β-花生酰胺基-7α,12α,5β-胆烷-24-羧酸的制备方法
TWI572616B (zh) * 2011-06-16 2017-03-01 凱瑟拉生物製藥有限公司 去氧膽酸之組成物及用途及其相關方法
US20160175324A1 (en) * 2013-08-08 2016-06-23 Galderm Therapeutics Ltd. Anti-acne compositions comprising bile acid-fatty acid conjugates
DK3077047T3 (da) * 2013-12-04 2019-07-15 Galmed Res & Development Ltd Aramcholsalte
US11571431B2 (en) 2013-12-04 2023-02-07 Galmed Research And Development Ltd Aramchol salts
WO2016199137A1 (en) 2015-06-10 2016-12-15 Galmed Research And Development Ltd. Low dose compositions of aramchol salts
WO2015186126A1 (en) * 2014-06-01 2015-12-10 Galmed Research And Development Ltd. Fatty acid bile acid conjugates for treatment of lipodystrophy
JOP20200092A1 (ar) 2014-11-10 2017-06-16 Alnylam Pharmaceuticals Inc تركيبات iRNA لفيروس الكبد B (HBV) وطرق لاستخدامها
IL243707A0 (en) 2016-01-20 2016-05-01 Galmed Res And Dev Ltd Treatment to regulate the microbiota in the intestine
CN106496300B (zh) * 2016-10-19 2018-05-18 上海博志研新药物技术有限公司 花生胆酸及其中间体的制备方法
US11197870B2 (en) 2016-11-10 2021-12-14 Galmed Research And Development Ltd Treatment for hepatic fibrosis
BR112019009509A2 (pt) * 2016-11-10 2019-07-30 Galmed Res And Development Ltd inibição de fibrose em pacientes com doença hepática gordurosa não alcoólica
US11324820B2 (en) 2017-04-18 2022-05-10 Alnylam Pharmaceuticals, Inc. Methods for the treatment of subjects having a hepatitis b virus (HBV) infection
CN110730785B (zh) 2017-06-07 2022-05-17 苏州科睿思制药有限公司 一种脂肪酸胆汁酸偶合物的晶型及其制备方法和用途
EP3837366A1 (en) 2018-08-13 2021-06-23 Alnylam Pharmaceuticals, Inc. Hepatitis b virus (hbv) dsrna agent compositions and methods of use thereof
IT202000000328A1 (it) 2020-01-10 2021-07-10 Ice S P A Metodo di preparazione dell'aramchol
CN114524857B (zh) * 2022-02-22 2023-06-30 中国科学院微生物研究所 胆酸衍生物及其应用
CN116687850A (zh) 2022-02-24 2023-09-05 甘莱制药有限公司 包含环状膦酸酯化合物的药物组合物及其制备方法与用途
WO2023227723A1 (en) * 2022-05-26 2023-11-30 Pharmazell Gmbh An improved process for the preparation of aramchol and salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856953A (en) * 1973-05-15 1974-12-24 Intellectual Property Dev Corp Method of treating fatty liver
IT1167478B (it) * 1981-07-24 1987-05-13 Carlo Scolastico Derivati dell'acido ursodesossicolico
IT1167479B (it) * 1981-07-24 1987-05-13 Carlo Scolastico Derivati dell'acido chenodesossicolico
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
IL123998A (en) * 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
DE19824123A1 (de) * 1998-05-29 1999-12-02 Hoechst Marion Roussel De Gmbh Gallensäurederivat, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung

Also Published As

Publication number Publication date
BR9909908B1 (pt) 2014-03-18
WO1999052932A1 (en) 1999-10-21
JP2002511482A (ja) 2002-04-16
CA2325933A1 (en) 1999-10-21
NZ507309A (en) 2003-06-30
BRPI9909908B8 (pt) 2021-05-25
US6384024B1 (en) 2002-05-07
PT1071702E (pt) 2003-01-31
HUP0101653A2 (hu) 2001-12-28
HU229513B1 (en) 2014-01-28
US6589946B2 (en) 2003-07-08
EA200000888A1 (ru) 2001-04-23
JP5031942B2 (ja) 2012-09-26
DE69902647D1 (de) 2002-10-02
AU742944B2 (en) 2002-01-17
KR100615560B1 (ko) 2006-08-25
EA003392B1 (ru) 2003-04-24
ES2183526T3 (es) 2003-03-16
IL123998A (en) 2004-09-27
ATE222923T1 (de) 2002-09-15
CN1296492A (zh) 2001-05-23
CN100386339C (zh) 2008-05-07
EP1071702B1 (en) 2002-08-28
UA70318C2 (uk) 2004-10-15
US20020091111A1 (en) 2002-07-11
DK1071702T3 (da) 2002-12-30
US6395722B1 (en) 2002-05-28
EP1071702A1 (en) 2001-01-31
NO20004998L (no) 2000-12-06
CZ20003625A3 (cs) 2001-01-17
ID26042A (id) 2000-11-16
NO316875B1 (no) 2004-06-07
PL199271B1 (pl) 2008-09-30
CZ300824B6 (cs) 2009-08-19
DE69902647T2 (de) 2003-04-24
AU3051599A (en) 1999-11-01
CA2325933C (en) 2008-06-10
KR20010042342A (ko) 2001-05-25
HUP0101653A3 (en) 2002-02-28
PL343360A1 (en) 2001-08-13
TR200002876T2 (tr) 2000-12-21
BR9909908A (pt) 2000-12-26
NO20004998D0 (no) 2000-10-04

Similar Documents

Publication Publication Date Title
PL343360A1 (en) Fatty acid derivatives of bile acids and bile acid derivatives
BG103335A (en) Application of fumaric acid derivatives
TR199801195T2 (xx) Tedavide yararl� kinolin ve kinozilin bile�ikleri.
WO2003022210A3 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
WO1997044063A3 (en) Dha-pharmaceutical agent conjugates
JO2503B1 (en) Benzathiazole derivatives
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
WO1997002046A3 (de) Saccharid-konjugate
MXPA03009553A (es) Uso de acido biliar o conjugados de acidos grasos de sales biliares.
DE50211929D1 (en) Pyrimidinderivate
NO940777D0 (no) Anvendelse av et pregnanderivat
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
WO2001030804A3 (en) Salt form of a conjugate useful in the treatment of prostate cancer
CA2375743A1 (en) Methods and compositions for the support, regeneration and repair of connective tissues
AP9400608A0 (en) "New nicotinic acid derivative".
HK1026610A1 (en) Anhydrovinblastine for the treatment of cancer
WO1999010371A3 (de) Cyclopeptidderivate als adhäsionsinhibitoren